{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T23:14:28Z","timestamp":1788563668983,"version":"build-2803163510"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,4]]},"DOI":"10.7759\/cureus.115796","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T23:03:22Z","timestamp":1788563002000},"source":"Crossref","is-referenced-by-count":0,"title":["Cerebral Aspergillosis in a Patient on Ibrutinib: A Case of Diagnostic Ambiguity and Multidisciplinary Care"],"prefix":"10.7759","author":[{"given":"Konstantinos Iason","family":"Tompler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Osthoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.idnow.2021.04.002","article-title":"Clinical manifestations, diagnosis, and treatment outcome of CNS aspergillosis: a systematic review of 235 cases","volume":"51","author":"Meena DS","year":"2021","unstructured":"Meena DS, Kumar D, Bohra GK, Kumar G. Clinical manifestations, diagnosis, and treatment outcome of CNS aspergillosis: a systematic review of 235 cases. Infect Dis Now. 2021, 51:654-60. 10.1016\/j.idnow.2021.04.002","journal-title":"Infect Dis Now"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-025-01241-0","article-title":"Cerebral aspergillosis: diagnostic challenges, therapeutic strategies, and future research","volume":"40","author":"Chantelot L","year":"2026","unstructured":"Chantelot L, Sitterl\u00e9 E, Poir\u00e9e S, Jullien V, Danion F, Serris A. Cerebral aspergillosis: diagnostic challenges, therapeutic strategies, and future research. CNS Drugs. 2026, 40:43-58. 10.1007\/s40263-025-01241-0","journal-title":"CNS Drugs"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics13050387","article-title":"Cerebral infectious opportunistic lesions in a patient with acute myeloid leukaemia: the challenge of diagnosis and clinical management","volume":"13","author":"Cavazza G","year":"2024","unstructured":"Cavazza G, Motto C, Regna-Gladin C, et al.. Cerebral infectious opportunistic lesions in a patient with acute myeloid leukaemia: the challenge of diagnosis and clinical management. Antibiotics (Basel). 2024, 13:10.3390\/antibiotics13050387","journal-title":"Antibiotics (Basel)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3109\/02688697.2016.1139046","article-title":"Management of granulomatous cerebral aspergillosis in immunocompetent adult patients: a review","volume":"30","author":"Ellenbogen JR","year":"2016","unstructured":"Ellenbogen JR, Waqar M, Cooke RP, Javadpour M. Management of granulomatous cerebral aspergillosis in immunocompetent adult patients: a review. Br J Neurosurg. 2016, 30:280-5. 10.3109\/02688697.2016.1139046","journal-title":"Br J Neurosurg"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-020-4894-2","article-title":"Isolated central nervous system Aspergillosis infection in a chronic lymphocytic leukemia patient on ibrutinib: a case report","volume":"20","author":"Le TH","year":"2020","unstructured":"Le TH, Kumar V, Gondal K, Barnes M, Siddique H, Buttar B, Kaell A. Isolated central nervous system Aspergillosis infection in a chronic lymphocytic leukemia patient on ibrutinib: a case report. BMC Infect Dis. 2020, 20:175. 10.1186\/s12879-020-4894-2","journal-title":"BMC Infect Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2020.1728749","article-title":"Ibrutinib related cerebral aspergillosis successfully treated with isavuconazole: a case report","volume":"61","author":"Nyga R","year":"2020","unstructured":"Nyga R, Delette C, Mabille C, et al.. Ibrutinib related cerebral aspergillosis successfully treated with isavuconazole: a case report. Leuk Lymphoma. 2020, 61:1760-2. 10.1080\/10428194.2020.1728749","journal-title":"Leuk Lymphoma"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1556\/030.2025.02528","article-title":"Invasive pulmonary and central nervous system aspergillosis: a case report and literature review","volume":"72","author":"Lu W","year":"2025","unstructured":"Lu W, Ji R, Li W. Invasive pulmonary and central nervous system aspergillosis: a case report and literature review. Acta Microbiol Immunol Hung. 2025, 72:9-15. 10.1556\/030.2025.02528","journal-title":"Acta Microbiol Immunol Hung"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1172\/JCI176142","article-title":"BTK drives neutrophil activation for sterilizing antifungal immunity","volume":"134","author":"Desai JV","year":"2024","unstructured":"Desai JV, Zarakas MA, Wishart AL, et al.. BTK drives neutrophil activation for sterilizing antifungal immunity. J Clin Invest. 2024, 134:10.1172\/JCI176142","journal-title":"J Clin Invest"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab1026","article-title":"Incidence of invasive fungal infections in patients initiating ibrutinib and other small molecule kinase inhibitors\u2014United States, July 2016-June 2019","volume":"75","author":"Gold JA","year":"2022","unstructured":"Gold JA, Tolu SS, Chiller T, Benedict K, Jackson BR. Incidence of invasive fungal infections in patients initiating ibrutinib and other small molecule kinase inhibitors\u2014United States, July 2016-June 2019. Clin Infect Dis. 2022, 75:334-7. 10.1093\/cid\/ciab1026","journal-title":"Clin Infect Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2025.102691","article-title":"Isolated brain abscess caused by Aspergillus tubingensis in a patient with alcoholic liver cirrhosis","volume":"31","author":"Inaba T","year":"2025","unstructured":"Inaba T, Minami K, Ishioka H, Sekiguchi K, Watanabe A, Hatakeyama S. Isolated brain abscess caused by Aspergillus tubingensis in a patient with alcoholic liver cirrhosis. J Infect Chemother. 2025, 31:102691. 10.1016\/j.jiac.2025.102691","journal-title":"J Infect Chemother"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2024.107000","article-title":"Invasive Aspergillosis with impaired neutrophil responses against Aspergillus fumigatus in patients treated with acalabrutinib-findings from three cases","volume":"142","author":"Blaize M","year":"2024","unstructured":"Blaize M, Thizy G, Boissonnas A, et al.. Invasive Aspergillosis with impaired neutrophil responses against Aspergillus fumigatus in patients treated with acalabrutinib-findings from three cases. Int J Infect Dis. 2024, 142:107000. 10.1016\/j.ijid.2024.107000","journal-title":"Int J Infect Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2018.1494271","article-title":"A case of ibrutinib-associated aspergillosis presenting with central nervous system, myocardial, pulmonary, intramuscular, and subcutaneous abscesses","volume":"60","author":"McCarter SJ","year":"2019","unstructured":"McCarter SJ, Vijayvargiya P, Sidana S, et al.. A case of ibrutinib-associated aspergillosis presenting with central nervous system, myocardial, pulmonary, intramuscular, and subcutaneous abscesses. Leuk Lymphoma. 2019, 60:559-61. 10.1080\/10428194.2018.1494271","journal-title":"Leuk Lymphoma"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.57923","article-title":"A rare case of invasive central nervous system Aspergillus niger in a previously immunocompetent patient after corticosteroid treatment for COVID-19","volume":"16","author":"Saleh H","year":"2024","unstructured":"Saleh H, Abraham P, Chahine H, Subbiah S, Grace-Abraham N. A rare case of invasive central nervous system Aspergillus niger in a previously immunocompetent patient after corticosteroid treatment for COVID-19. Cureus. 2024, 16:e57923. 10.7759\/cureus.57923","journal-title":"Cureus"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4045\/tidsskr.20.0825","article-title":"[Cerebral aspergillosis]","volume":"141","author":"Frascheri L","year":"2021","unstructured":"Frascheri L, Breivik B, Helleren R. [Cerebral aspergillosis]. Tidsskr Nor Laegeforen. 2021, 141:10.4045\/tidsskr.20.0825","journal-title":"Tidsskr Nor Laegeforen"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-025-11457-6","article-title":"Meningitis caused by Aspergillus fumigatus: a case report","volume":"25","author":"Zhang Y","year":"2025","unstructured":"Zhang Y, Ma Y, Yue R, et al.. Meningitis caused by Aspergillus fumigatus: a case report. BMC Infect Dis. 2025, 25:1051. 10.1186\/s12879-025-11457-6","journal-title":"BMC Infect Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2024.12.032","article-title":"Fungal infection in patients treated with Bruton tyrosine kinase inhibitor-from epidemiology to clinical outcome: a systematic review","volume":"31","author":"Gibert C","year":"2025","unstructured":"Gibert C, Blaize M, Fekkar A. Fungal infection in patients treated with Bruton tyrosine kinase inhibitor-from epidemiology to clinical outcome: a systematic review. Clin Microbiol Infect. 2025, 31:731-9. 10.1016\/j.cmi.2024.12.032","journal-title":"Clin Microbiol Infect"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2013.08.003","article-title":"The CARE guidelines: consensus-based clinical case report guideline development","volume":"67","author":"Gagnier JJ","year":"2014","unstructured":"Gagnier JJ, Kienle G, Altman DG, Moher D, Sox H, Riley D. The CARE guidelines: consensus-based clinical case report guideline development. J Clin Epidemiol. 2014, 67:46-51. 10.1016\/j.jclinepi.2013.08.003","journal-title":"J Clin Epidemiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-802395-2.00018-3","article-title":"Parasitic and fungal infections","author":"Deigendesch N","year":"2017","unstructured":"Deigendesch N, Costa Nunez J, Stenzel W. Parasitic and fungal infections. Handbook of Clinical Neurology. Kovacs GG, Alafuzoff I (ed): Elsevier B.V., Amsterdam; 2017. 145:245-62. 10.1016\/B978-0-12-802395-2.00018-3"},{"key":"ref19","unstructured":"IMBRUVICA (ibrutinib) capsules, tablets, and oral suspension. prescribing information. (2025). Accessed: 21.10.2025: https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=0dfd0279-ff17-4ea9-89be-9803c71bab44&utm_source."},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-025-02572-2","article-title":"Diagnosis and treatment of invasive pulmonary aspergillosis in critically ill intensive care patients: executive summary of the German national guideline (AWMF 113-005)","volume":"53","author":"Wichmann D","year":"2025","unstructured":"Wichmann D, Hoenigl M, Koehler P, et al.. Diagnosis and treatment of invasive pulmonary aspergillosis in critically ill intensive care patients: executive summary of the German national guideline (AWMF 113-005). Infection. 2025, 53:1299-310. 10.1007\/s15010-025-02572-2","journal-title":"Infection"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/456223-cerebral-aspergillosis-in-a-patient-on-ibrutinib-a-case-of-diagnostic-ambiguity-and-multidisciplinary-care","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T23:03:23Z","timestamp":1788563003000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/456223-cerebral-aspergillosis-in-a-patient-on-ibrutinib-a-case-of-diagnostic-ambiguity-and-multidisciplinary-care"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,4]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.115796","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,4]]}}}